Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
February 23, 2023 at 12:41 am
Abera Bioscience AB reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was SEK 0.014 million compared to SEK 0.421 million a year ago. Net loss was SEK 4.53 million compared to SEK 2.61 million a year ago. Basic loss per share from continuing operations was SEK 0.38 compared to SEK 0.25 a year ago. Diluted loss per share from continuing operations was SEK 0.38 compared to SEK 0.25 a year ago.
For the full year, revenue was SEK 1.85 million compared to SEK 1.19 million a year ago. Net loss was SEK 19.38 million compared to SEK 9.17 million a year ago. Basic loss per share from continuing operations was SEK 1.66 compared to SEK 0.9 a year ago. Diluted loss per share from continuing operations was SEK 1.66 compared to SEK 0.9 a year ago.